Virginia Fortuna

Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Dried Blood Spot for CXCL-10 and Tacrolimus: Integrated Non-Invasive Monitoring to Guide Personalized Treatment in Adult Kidney Transplant Recipients.

Dried Blood Spot for CXCL-10 and Tacrolimus: Integrated Non-Invasive Monitoring to Guide Personalized Treatment in Adult Kidney Transplant Recipients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 22, 2025

Pharmacogenetic Influences on Individual Responses to Ocular Hypotensive Agents in Glaucoma Patients.

Pharmacogenetic Influences on Individual Responses to Ocular Hypotensive Agents in Glaucoma Patients.

Journal: Pharmaceutics

Published: December 21, 2024

Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.

Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 02, 2024

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients.

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients.

Journal: International journal of molecular sciences

Published: December 12, 2022

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections.

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections.

Journal: The Journal of antimicrobial chemotherapy

Published: November 11, 2021

Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients.

Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients.

Journal: PloS one

Published: August 21, 2020

Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.

Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 14, 2019

Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients.

Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients.

Journal: Frontiers in immunology

Published: December 18, 2018

Antipsychotic therapy amongst Cytochrome P450 2D6 poor metabolizers in the clinical practice: A case report.

Antipsychotic therapy amongst Cytochrome P450 2D6 poor metabolizers in the clinical practice: A case report.

Journal: Actas espanolas de psiquiatria

Published: September 01, 2017

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.

Journal: Immunobiology

Published: August 12, 2015

Development and validation of a UHPLC diode array detector method for meropenem quantification in human plasma.

Development and validation of a UHPLC diode array detector method for meropenem quantification in human plasma.

Journal: Clinical biochemistry

Published: April 29, 2014

Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients.

Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients.

Journal: Cytokine

Published: June 19, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026